Ledger.Open graph →

SEC Form D · filed October 31, 2024

Seaport Therapeutics, Inc

Offering

$226.0M

Sold

$225.9M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BOSTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

A. Rich · Boston, MAExec · Director James I. Healy · Boston, MADirector Michael Chen · Boston, MAExec Lana Gladstein · Boston, MAExec Daphne Zohar · Boston, MAExec · Director Antony Loebel · Boston, MAExec David I. Wheadon · Boston, MADirector Eric Green · Boston, MAExec Robert I. Nelsen · Boston, MADirector Steven Paul · Boston, MADirector Bharatt I. Chowrira · Boston, MADirector Denice I. Torres · Boston, MADirector Eric Elenko · Boston, MADirector Jason I. Pitts · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗